| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -60,146 | 5,193 |
| Effect of exchange rate changes on cash | 2,704 | 2,497 |
| Net increase (decrease) in cash and cash equivalents | 52,395 | 16,619 |
| Cash and cash equivalents at beginning of period | 58,535 | - |
| Cash and cash equivalents at end of period | 110,930 | - |
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)